Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation

NCT01582945 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01582945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01582945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder